发明授权
- 专利标题： Therapeutic agents for achondroplasia
- 专利标题（中）： 软骨发育的治疗剂
-
申请号： US10218109申请日： 2002-08-14
-
公开(公告)号： US06743425B2公开(公告)日： 2004-06-01
- 发明人: Kazuwa Nakao
- 申请人： Kazuwa Nakao
- 优先权： JP2001-301586 20010928; JP2001-310322 20011005
- 主分类号： A61K3847
- IPC分类号： A61K3847
摘要：
The present invention aims to provide novel therapeutic agents for achondroplasia caused by mutations in FGFR3. Therapeutic agents for achondroplasia caused by the cartilage growth inhibition resulting from mutations in the gene for fibroblast growth factor receptor 3 (FGFR3), comprising a substance activating guanylyl cyclase B (GC-B) as an active ingredient are disclosed.
公开/授权文献
- US20030068313A1 Therapeutic agents for achondroplasia 公开/授权日：2003-04-10
信息查询
